Finasteride recalls
Finasteride products have been recalled 3 times, most recently on 8 Mar 2023. The recalling company is usually Accord Healthcare. The most common reason is manufacturing (cgmp) deviations.
Total recalls3since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 8 Mar 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 67%Class III 1 33%
Why finasteride is recalled
Companies
Product types
By year
All finasteride recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Finasteride Tablets USP, 1 mg recalled by Accord HealthcareFinasteride | Accord Healthcare | Manufacturing (CGMP) Deviations | PR |
| Drug | CLASS II | Finasteride Tablets USP, 5 mg recalled by Accord HealthcareFinasteride | Accord Healthcare | Manufacturing (CGMP) Deviations | PR |
| Drug | CLASS III | Finasteride Tablets, USP 5 mg recalled by Hetero Drugs Ltd. - Unit 1Finasteride | Hetero Drugs Ltd. - Unit 1 | Other | NJ |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.